Exact Mass: 349.2287

Exact Mass Matches: 349.2287

Found 274 metabolites which its exact mass value is equals to given mass value 349.2287, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cetiedil

3-Thiopheneacetic acid, alpha-cyclohexyl-, 2-(hexahydro-1H-azepin-1-yl)ethyl ester, hydrochloride (1:1)

C20H31NO2S (349.2075)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D006401 - Hematologic Agents > D000986 - Antisickling Agents ATC code: C04AX26

   

AMD-070

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

C21H27N5 (349.2266)


C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist > C107589 - CXCR4 Inhibitor

   

Murrayazolinine

2-{13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaen-19-yl}propan-2-ol

C23H27NO2 (349.2042)


Murrayazolinine is found in herbs and spices. Murrayazolinine is an alkaloid from the stem bark of Murraya koenigii (curryleaf tree

   

Demethoxyfumitremorgin C

12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4(9),5,7-tetraene-14,20-dione

C21H23N3O2 (349.179)


Demethoxyfumitremorgin C is produced by Aspergillus fumigatu

   

Mahanimbinine

5-{3,5-dimethyl-3H,11H-pyrano[3,2-a]carbazol-3-yl}-2-methylpentan-2-ol

C23H27NO2 (349.2042)


Mahanimbinine is found in herbs and spices. Mahanimbinine is an alkaloid from leaves of Murraya koenigii (curryleaf tree

   

Coutaric acid

4-[(2R)-2-(Aminomethyl)-2-(hydroxymethyl)-5-oxopyrrolidin-1-YL]-3-[(1-ethylpropyl)amino]benzoic acid

C18H27N3O4 (349.2001)


Coutaric acid is a fecal metabolite from grape juice. It may also be in urine. It is an ester formed from coumaric acid and tartaric acid.

   

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

C21H27N5 (349.2266)


   

Abeado

5-(((Z)-4-Amino-2-butenyl)methylamino)-5-deoxyadenosine

C15H23N7O3 (349.1862)


   

Abiraterone

2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-7,13-dien-5-ol

C24H31NO (349.2406)


   

N-Hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-2-propenamide

N-Hydroxy3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enimidate

C21H23N3O2 (349.179)


   

Dipipanone

4,4-diphenyl-6-(piperidin-1-yl)heptan-3-one

C24H31NO (349.2406)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

Dansylamidohexamethylamine

N-(6-aminohexyl)-5-(dimethylamino)naphthalene-1-sulfonamide

C18H27N3O2S (349.1824)


   

Vernakalant

1-[2-[2-(3,4-Dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol

C20H31NO4 (349.2253)


   

Sodium dodecylbenzenesulfonate

Sodium 3-dodecylbenzene-1-sulphonic acid

C18H30NaO3S (349.1813)


Surfactant for use in washing or lye peeling of fruit and vegetables and in poultry scald solutions

   

Arachin

2-methoxy-6-[(2E)-4-(2-methylpiperidin-1-yl)-1,2-dihydroquinazolin-2-ylidene]cyclohexa-2,4-dien-1-one

C21H23N3O2 (349.179)


Arachin is a member of the class of compounds known as quinazolinamines. Quinazolinamines are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. Arachin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Arachin can be found in peanut, which makes arachin a potential biomarker for the consumption of this food product. Kodashim or Kodshim or Qodhashim (Hebrew: קדשים‎ "Holy Things") is the fifth Order in the Mishnah (also the Tosefta and Talmud). Of the six Orders of the Mishnah, it is the third longest. Kodoshim deals largely with the religious service within the Temple in Jerusalem, the qorbanot ("sacrificial offerings"), and other subjects considered or related to these "Holy Things" .

   

(5Z)-(15S)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate

(5Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-[(1E)-3-oxooct-1-en-1-yl]cyclopentyl]hept-5-enoate

C20H29O5 (349.2015)


(5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate, also known as 15-dehydro-prostaglandin e2 anion, is a member of the class of compounds known as prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid (5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate can be found in a number of food items such as maitake, green zucchini, yellow pond-lily, and canada blueberry, which makes (5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate a potential biomarker for the consumption of these food products. (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate, also known as 15-dehydro-prostaglandin e2 anion, is a member of the class of compounds known as prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate can be found in a number of food items such as maitake, green zucchini, yellow pond-lily, and canada blueberry, which makes (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate a potential biomarker for the consumption of these food products.

   

12,13-Dihydroprolyl-2-(1,1-dimethylallyltryptophyl) diketopiperazine

12,13-Dihydroprolyl-2-(1,1-dimethylallyltryptophyl) diketopiperazine

C21H23N3O2 (349.179)


   

Preparaherquamide

Preparaherquamide

C22H27N3O (349.2154)


   

Acetyllycoclavine

Acetyllycoclavine

C20H31NO4 (349.2253)


   

Murrayamine O

Murrayamine O

C23H27NO2 (349.2042)


   
   
   

Neovasipyridone B

Neovasipyridone B

C21H35NO3 (349.2617)


   

Acetylfawcettiine

beta-Lofoline acetate

C20H31NO4 (349.2253)


   

Neovasipyridone A

Neovasipyridone A

C21H35NO3 (349.2617)


   
   
   
   
   

5-Fluoro AMB metabolite 7

5-Fluoro AMB metabolite 7

C18H24FN3O3 (349.1802)


   
   
   

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1h-indole-3-carboxamide

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1h-indole-3-carboxamide

C21H23N3O2 (349.179)


   
   

CHEMBL3431128

CHEMBL3431128

C19H23N7 (349.2015)


   

cylindricine E

cylindricine E

C21H35NO3 (349.2617)


   

3-[2-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-1,2,3,4,6,7-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

3-[2-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-1,2,3,4,6,7-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

C21H23N3O2 (349.179)


   

19-(alpha-Methyl)-18-deoxy-15,22-dihydro-3-iso-cadamin|5-methyl-3,5,7,8,13,13b,14,14a-octahydro-indolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridine-1-carboxylic acid methyl ester

19-(alpha-Methyl)-18-deoxy-15,22-dihydro-3-iso-cadamin|5-methyl-3,5,7,8,13,13b,14,14a-octahydro-indolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridine-1-carboxylic acid methyl ester

C21H23N3O2 (349.179)


   

tricalysiamide D

tricalysiamide D

C20H31NO4 (349.2253)


   

(-)-alancine|alancine

(-)-alancine|alancine

C19H27NO5 (349.1889)


   

Mahanimbinine

5-{5,8-dimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaen-5-yl}-2-methylpentan-2-ol

C23H27NO2 (349.2042)


   

SCHEMBL4904241

SCHEMBL4904241

C23H27NO2 (349.2042)


   

Oxime-(3alpha,5beta,20R)-3,20-Dihydroxypregnan-11-one

Oxime-(3alpha,5beta,20R)-3,20-Dihydroxypregnan-11-one

C21H35NO3 (349.2617)


   

Murrayazolinine

2-{13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0^{2,14}.0^{3,11}.0^{5,10}]icosa-2,5,7,9,11,13-hexaen-19-yl}propan-2-ol

C23H27NO2 (349.2042)


   

(4R*,4aS*,6R*,7S*,7aR*)-octahydro-2,4,7-trimethyl-1H-cyclopenta[c]pyridin-6-yl (2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dienoate|incarvine E

(4R*,4aS*,6R*,7S*,7aR*)-octahydro-2,4,7-trimethyl-1H-cyclopenta[c]pyridin-6-yl (2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dienoate|incarvine E

C21H35NO3 (349.2617)


   
   

axinysaline A

axinysaline A

C21H35NO3 (349.2617)


   

brevianamide V

brevianamide V

C21H23N3O2 (349.179)


   

deoxydihydroisoaustamide

deoxydihydroisoaustamide

C21H23N3O2 (349.179)


   

prealmazole C

prealmazole C

C21H23N3O2 (349.179)


   

Reutericyclin

Reutericyclin

C20H31NO4 (349.2253)


   

(-)-lepadin C|(2S,3S,4aS,5S,8aR)-2-methyl-5-[(1E,3E)-7-oxo-1,3-octadienyl]decahydro-3-quinolinyl hydroxyacetate|lepadin C

(-)-lepadin C|(2S,3S,4aS,5S,8aR)-2-methyl-5-[(1E,3E)-7-oxo-1,3-octadienyl]decahydro-3-quinolinyl hydroxyacetate|lepadin C

C20H31NO4 (349.2253)


   

4-dihydroconsabatine

4-dihydroconsabatine

C20H31NO4 (349.2253)


   
   
   
   
   
   
   
   

Arachidonoyl-2-Fluoroethylamide

Arachidonoyl-2-Fluoroethylamide

C22H36FNO (349.2781)


   
   
   
   
   

Abiraterone

Abiraterone (CB-7598)

C24H31NO (349.2406)


A 3beta-sterol that is androsta-5,16-dien-3beta-ol substituted at position 17 by a 3-pyridyl group. Administered as the O-acetate, it is used for treatment of metastatic castrate-resistant prostate cancer. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C471 - Enzyme Inhibitor > C147923 - CYP17A1 Inhibitor

   
   

12,13-dehydroprolyl-2-(1,1-dimethylallyltryptophyl)diketopiperazine

12,13-dehydroprolyl-2-(1,1-dimethylallyltryptophyl)diketopiperazine

C21H23N3O2 (349.179)


   
   
   
   
   
   
   
   

dipipanone

dipipanone

C24H31NO (349.2406)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

2-fluoro Anandamide

N-(2-fluro-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C22H36FNO (349.2781)


   

MDA-19

(2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide, benzoic acid

C21H23N3O2 (349.179)


   

JWH018 adamantyl

1-pentyl-3-(1-adamantoyl)indole

C24H31NO (349.2406)


   

Coutaric acid

4-[(2R)-2-(aminomethyl)-2-(hydroxymethyl)-5-oxopyrrolidin-1-yl]-3-[(pentan-3-yl)amino]benzoic acid

C18H27N3O4 (349.2001)


   

Demethoxyfumitremorgin C

12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0^{3,11}.0^{4,9}.0^{15,19}]icosa-3(11),4,6,8-tetraene-14,20-dione

C21H23N3O2 (349.179)


An organic heteropentacyclic compound that is a mycotoxic indole alkaloid, consisting of fumitremorgin C lacking the 9-methoxy substituent.

   

SDBS Surfactant

sodium 4-dodecylbenzene-1-sulfonic acid

C18H30NaO3S (349.1813)


   

arachidonoyl-(2-fluoroethyl)amide

N-(2-fluoro-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C22H36NOF (349.2781)


   

L-Alanine, N-(1-carboxyethyl)- (9CI)

L-Alanine, N-(1-carboxyethyl)- (9CI)

C17H32ClNO4 (349.202)


   

3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-1H-indol-2-one

3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-1H-indol-2-one

C23H27NO2 (349.2042)


   

N,N-Dimethyl-N-octyl-1-octanaminium bromide

N,N-Dimethyl-N-octyl-1-octanaminium bromide

C18H40BrN (349.2344)


   

Vernakalant

Vernakalant

C20H31NO4 (349.2253)


C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent C93038 - Cation Channel Blocker

   

2-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL) PYRIDINE-4-BORONIC ACID PINACOL ESTER

2-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL) PYRIDINE-4-BORONIC ACID PINACOL ESTER

C18H32BNO3Si (349.2244)


   

1-Benzyl 4-tert-butyl 2-(aminomethyl) piperazine-1,4-dicarboxylate

1-Benzyl 4-tert-butyl 2-(aminomethyl) piperazine-1,4-dicarboxylate

C18H27N3O4 (349.2001)


   

azepan-2-one,butane-1,4-diol,hexanedioic acid

azepan-2-one,butane-1,4-diol,hexanedioic acid

C16H31NO7 (349.21)


   

5-(Bis(2-hydroxyethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester

5-(Bis(2-hydroxyethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester

C18H27N3O4 (349.2001)


   

3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[tris(propan-2-yl)silyl]-1H-pyrrole

3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[tris(propan-2-yl)silyl]-1H-pyrrole

C19H36BNO2Si (349.2608)


   

n-(3-acryloxy-2-hydroxypropyl)-3-aminopropyltriethoxysilane

n-(3-acryloxy-2-hydroxypropyl)-3-aminopropyltriethoxysilane

C15H31NO6Si (349.1921)


   

Trifluralin D14 (di-n-propyl D14)

Trifluralin D14 (di-n-propyl D14)

C13H2D14F3N3O4 (349.1972)


   

(R )-5-(2-aminopropyl)-1-(3-benzyloxypropyl) indoline-7-carbonitrile

(R )-5-(2-aminopropyl)-1-(3-benzyloxypropyl) indoline-7-carbonitrile

C22H27N3O (349.2154)


   

3-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

3-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C18H32BNO3Si (349.2244)


   

2-Nitrophenyl myristate

2-Nitrophenyl myristate

C20H31NO4 (349.2253)


   

Aluminum magnesium isopropoxide

Aluminum magnesium isopropoxide

C15H38AlMgO5 (349.2385)


   

TERT-BUTYL (S)-4-(CBZ-AMINO)-5-METHYL-3-OXOHEXANOATE

TERT-BUTYL (S)-4-(CBZ-AMINO)-5-METHYL-3-OXOHEXANOATE

C19H27NO5 (349.1889)


   
   

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-METHOXYBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-METHOXYBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

C19H27NO5 (349.1889)


   

1-[Decanoyl(methyl)amino]-1-deoxy-D-glucitol

1-[Decanoyl(methyl)amino]-1-deoxy-D-glucitol

C17H35NO6 (349.2464)


   

9,9-dihexyl-2-Amino-9H-fluorene

9,9-dihexyl-2-Amino-9H-fluorene

C25H35N (349.2769)


   

TERT-BUTYL (2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)CARBAMATE

TERT-BUTYL (2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)CARBAMATE

C18H28BNO5 (349.206)


   

6-([(tert-Butyldimethylsilyl)oxy]methyl)pyridine-3-boronic acid pinacol ester

6-([(tert-Butyldimethylsilyl)oxy]methyl)pyridine-3-boronic acid pinacol ester

C18H32BNO3Si (349.2244)


   

sodium lauroamphoacetate

sodium lauroamphoacetate

C18H34N2NaO3 (349.2467)


   

3-Pinacolateboryl-1H-pyrrole

3-Pinacolateboryl-1H-pyrrole

C19H36BNO2Si (349.2608)


   

Sodium N-tetradecanoyl-L-valinate

Sodium N-tetradecanoyl-L-valinate

C19H36NNaO3 (349.2593)


   

Sodium N-hexadecanoyl-L-alaninate

Sodium N-hexadecanoyl-L-alaninate

C19H36NNaO3 (349.2593)


   

Myristoylcholine Chloride

Myristoylcholine Chloride

C19H40ClNO2 (349.2747)


   

1-METHYL-N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)-1H-BENZO[D]IMIDAZOL-2-AMINE

1-METHYL-N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)-1H-BENZO[D]IMIDAZOL-2-AMINE

C20H24BN3O2 (349.1961)


   

Panobinostat

Panobinostat

C21H23N3O2 (349.179)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

TRIS(4-METHOXYPHENYL)BORANE-AMMONIA COMPLEX

TRIS(4-METHOXYPHENYL)BORANE-AMMONIA COMPLEX

C21H24BNO3 (349.1849)


   

sodium N-methyl-N-(1-oxohexadecyl)aminoacetate

sodium N-methyl-N-(1-oxohexadecyl)aminoacetate

C19H36NNaO3 (349.2593)


   

Tetradecyldimethylethylammonium bromide

Tetradecyldimethylethylammonium bromide

C18H40BrN (349.2344)


   

4-Nitrophenyl myristate

4-Nitrophenyl myristate

C20H31NO4 (349.2253)


   

2-piperidin-1-ylethyl 2,2-diphenylcyclopropane-1-carboxylate

2-piperidin-1-ylethyl 2,2-diphenylcyclopropane-1-carboxylate

C23H27NO2 (349.2042)


   

R-1-N-Cbz-4-N-Boc-2-aminomethylpiparazine

R-1-N-Cbz-4-N-Boc-2-aminomethylpiparazine

C18H27N3O4 (349.2001)


   

1-tert-butyl 2-Methyl 2-(2-(benzylaMino)ethyl)azetidine-1,2-dicarboxylate

1-tert-butyl 2-Methyl 2-(2-(benzylaMino)ethyl)azetidine-1,2-dicarboxylate

C19H29N2O4 (349.2127)


   
   

N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide

N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide

C21H35NO3 (349.2617)


   

MENTHOLGLUCURONIC ACID AMMONIUM SALT

MENTHOLGLUCURONIC ACID AMMONIUM SALT

C16H31NO7 (349.21)


   

Methylamino-phenylalanyl-leucyl-hydroxamic acid

Methylamino-phenylalanyl-leucyl-hydroxamic acid

C18H27N3O4 (349.2001)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

   

1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Phenylurea

1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Phenylurea

C20H23N5O (349.1903)


   

N-(1H-benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

N-(1H-benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

C21H27N5 (349.2266)


   

1-Azabicyclo[2.2.2]octan-3-yl-bis(3,4-dimethylphenyl)methanol

1-Azabicyclo[2.2.2]octan-3-yl-bis(3,4-dimethylphenyl)methanol

C24H31NO (349.2406)


   

2-(cyclohexylamino)-N-[(diphenylmethylene)amino]propanamide

2-(cyclohexylamino)-N-[(diphenylmethylene)amino]propanamide

C22H27N3O (349.2154)


   
   

cis-4-Methyl-N-[(1S)-3-(methylsulfanyl)-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide

cis-4-Methyl-N-[(1S)-3-(methylsulfanyl)-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide

C18H27N3O2S (349.1824)


   

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-4-methylpentanoic acid

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-4-methylpentanoic acid

C18H27N3O4 (349.2001)


   

resolvin E1(1-)

resolvin E1(1-)

C20H29O5- (349.2015)


An icosanoid anion resulting from the removal of a proton from the carboxy group of resolvin E1; major species at pH 7.3.

   

5(S)-hydroperoxy-18(R)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

5(S)-hydroperoxy-18(R)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

C20H29O5- (349.2015)


An icosanoid anion arising from deprotonation of the carboxylic acid function of 5(S)-hydroperoxy-18(R)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoic acid; major species at pH 7.3.

   

15-dehydro-prostaglandin E2(1-)

15-dehydro-prostaglandin E2(1-)

C20H29O5- (349.2015)


Conjugate base of 15-dehydro-prostaglandin E2.

   

15-dehydro-prostaglandin I2(1-)

15-dehydro-prostaglandin I2(1-)

C20H29O5- (349.2015)


Conjugate base of 15-dehydro-prostaglandin I2.

   

15-dehydro-prostaglandin D2(1-)

15-dehydro-prostaglandin D2(1-)

C20H29O5- (349.2015)


Conjugate base of 15-dehydro-prostaglandin D2.

   

(6E)-2-methoxy-6-[4-(2-methylpiperidin-1-yl)-1H-quinazolin-2-ylidene]cyclohexa-2,4-dien-1-one

(6E)-2-methoxy-6-[4-(2-methylpiperidin-1-yl)-1H-quinazolin-2-ylidene]cyclohexa-2,4-dien-1-one

C21H23N3O2 (349.179)


   

2-[[[(E)-4-aminobut-2-enyl]-methylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol

2-[[[(E)-4-aminobut-2-enyl]-methylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol

C15H23N7O3 (349.1862)


   

Sodium;3-dodecylbenzenesulfonic acid

Sodium;3-dodecylbenzenesulfonic acid

C18H30NaO3S+ (349.1813)


   

Pyrrolo(1,2-a)pyrazine-1,4-dione, 3-((2-(1,1-dimethyl-2-propenyl)-1H-indol-3-yl)methyl)-2,3,6,7-tetrahydro-, (S)-

Pyrrolo(1,2-a)pyrazine-1,4-dione, 3-((2-(1,1-dimethyl-2-propenyl)-1H-indol-3-yl)methyl)-2,3,6,7-tetrahydro-, (S)-

C21H23N3O2 (349.179)


   

(5S)-hydroperoxy-18-hydroxy-EPE(1-)

(5S)-hydroperoxy-18-hydroxy-EPE(1-)

C20H29O5- (349.2015)


An icosanoid anion that is the conjugate base of (5S)-hydroperoxy-18-hydroxy-EPE, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(5S,6Z,8E,10E,12R,14Z,16E,18S)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

(5S,6Z,8E,10E,12R,14Z,16E,18S)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

C20H29O5- (349.2015)


   
   

N-ethyl-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-(phenylmethyl)propanamide

N-ethyl-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-(phenylmethyl)propanamide

C21H23N3O2 (349.179)


   

prostaglandin D3(1-)

prostaglandin D3(1-)

C20H29O5- (349.2015)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin D3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

15-oxolipoxin A4(1-)

15-oxolipoxin A4(1-)

C20H29O5- (349.2015)


A hydroxy fatty acid anion obtained by deprotonation of the carboxy function of 15-oxolipoxin A4; major species at pH 7.3.

   

20-oxoleukotriene B4(1-)

20-oxoleukotriene B4(1-)

C20H29O5- (349.2015)


A leukotriene anion that is the conjugate base of 20-oxoleukotriene B4 arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

N-(4-tert-butylphenyl)-2-[4-(1-imidazolyl)phenoxy]acetamide

N-(4-tert-butylphenyl)-2-[4-(1-imidazolyl)phenoxy]acetamide

C21H23N3O2 (349.179)


   

1-[1-Methyl-2-(1-pyrrolidinylmethyl)-5-benzimidazolyl]-3-phenylurea

1-[1-Methyl-2-(1-pyrrolidinylmethyl)-5-benzimidazolyl]-3-phenylurea

C20H23N5O (349.1903)


   

1-[4-(4-hydroxyphenyl)-1-piperazinyl]-3-(1H-indol-3-yl)-1-propanone

1-[4-(4-hydroxyphenyl)-1-piperazinyl]-3-(1H-indol-3-yl)-1-propanone

C21H23N3O2 (349.179)


   

(5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

(5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

C20H29O5- (349.2015)


An icosanoid anion that is the conjugate base of (5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoic acid, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

carbocyclic thromboxane A2(1-)

carbocyclic thromboxane A2(1-)

C21H33O4- (349.2379)


   

N-(4-Oxo-3,4-dihydro-quinazolin-2-ylmethyl)-N-phenethyl-butyramide

N-(4-Oxo-3,4-dihydro-quinazolin-2-ylmethyl)-N-phenethyl-butyramide

C21H23N3O2 (349.179)


   

(5Z,13E,15S,17Z)-11alpha,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oate

(5Z,13E,15S,17Z)-11alpha,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oate

C20H29O5- (349.2015)


   

(5Z,9S,11R,13E,15S,17Z)-15-Hydroxy-9,11-epidioxyprosta-5,13,17-trienoate

(5Z,9S,11R,13E,15S,17Z)-15-Hydroxy-9,11-epidioxyprosta-5,13,17-trienoate

C20H29O5- (349.2015)


   

N1-cyclohexyl-4-(4-fluorobenzyl)-1,4-diazepane-1-carbothioamide

N1-cyclohexyl-4-(4-fluorobenzyl)-1,4-diazepane-1-carbothioamide

C19H28FN3S (349.1988)


   

2-[(1-Methyl-2-benzimidazolyl)amino]-5-spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclopentane]one

2-[(1-Methyl-2-benzimidazolyl)amino]-5-spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclopentane]one

C20H23N5O (349.1903)


   

(5S,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoate

(5S,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoate

C20H29O5- (349.2015)


   

(7E,9E,11Z,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoate

(7E,9E,11Z,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoate

C20H29O5- (349.2015)


   

(6Z,8E,10E,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

(6Z,8E,10E,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

C20H29O5- (349.2015)


   

(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoic acid

(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoic acid

C18H27N3O4 (349.2001)


   
   
   
   
   

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

2-(dimethylamino)-1-[(1S,5R)-7-[4-(3-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

2-(dimethylamino)-1-[(1S,5R)-7-[4-(3-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

C22H27N3O (349.2154)


   

2-[(3R,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3R,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3R,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(1S,5R)-7-[4-(2-methylphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

(1S,5R)-7-[4-(2-methylphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

C22H27N3O (349.2154)


   

(1R,5S)-7-[4-(4-methylphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(1R,5S)-7-[4-(4-methylphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C22H27N3O (349.2154)


   

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

2-[(3R,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3R,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   
   
   
   
   

(5E)-2-(diethylamino)-5-[(4-methoxyphenyl)methylidene]-3-phenylimidazol-4-one

(5E)-2-(diethylamino)-5-[(4-methoxyphenyl)methylidene]-3-phenylimidazol-4-one

C21H23N3O2 (349.179)


   

2-N-methyl-2-N-[(1R)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]pyrimido[4,5-d]pyrimidine-2,5,7-triamine

2-N-methyl-2-N-[(1R)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]pyrimido[4,5-d]pyrimidine-2,5,7-triamine

C19H23N7 (349.2015)


   

(3S,8R,9R,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8R,9R,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

C24H31NO (349.2406)


   

1-[Diethyl(phenylethynyl)silyl]-2-(diethylsilyl)benzene

1-[Diethyl(phenylethynyl)silyl]-2-(diethylsilyl)benzene

C22H29Si2 (349.1808)


   

Cetiedil

2-(azepan-1-yl)ethyl 2-cyclohexyl-2-thiophen-3-ylacetate

C20H31NO2S (349.2075)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D006401 - Hematologic Agents > D000986 - Antisickling Agents ATC code: C04AX26

   

prostaglandin E3(1-)

prostaglandin E3(1-)

C20H29O5 (349.2015)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin E3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin H3(1-)

prostaglandin H3(1-)

C20H29O5 (349.2015)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin H3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(18S)-resolvin E1(1-)

(18S)-resolvin E1(1-)

C20H29O5 (349.2015)


An icosanoid anion that is the conjugate base of (18S)-resolvin E1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

NA-Ala 18:3(6Z,9Z,12Z)

NA-Ala 18:3(6Z,9Z,12Z)

C21H35NO3 (349.2617)


   

NA-Ala 18:3(9Z,12Z,15Z)

NA-Ala 18:3(9Z,12Z,15Z)

C21H35NO3 (349.2617)


   

NA-Dopamine 13:0

NA-Dopamine 13:0

C21H35NO3 (349.2617)


   

NA-Taurine 15:0

NA-Taurine 15:0

C17H35NO4S (349.2287)


   
   
   

ST 18:1;O2;Gly

ST 18:1;O2;Gly

C20H31NO4 (349.2253)


   

Reutericyclin

Reutericyclin

C20H31NO4 (349.2253)


Reutericyclin (Reutericycline), a unique tetramic acid, is an antibiotic produced by some strains of Lactobacillus reuteri. Reutericyclin (Reutericycline) exhibits a broad inhibitory spectrum including Lactobacillus spp., Bacillus subtilis, B. cereus, Enterococcus faecalis, Staphylococcus aureus, and Listeria innocua[1][2].

   

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazole-2,7-diol

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O2 (349.179)


   

11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C20H31NO2S (349.2075)


   

(1s,13s,15r,16r)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15r,16r)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

(3s)-1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3h,6h,7h-pyrrolo[1,2-a]pyrazin-4-one

(3s)-1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3h,6h,7h-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O2 (349.179)


   

(3z,8as)-1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

(3z,8as)-1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O2 (349.179)


   

(8e)-9-{[(2s)-1-hydroxy-3-(2-hydroxyphenyl)propan-2-yl]-c-hydroxycarbonimidoyl}non-8-enoic acid

(8e)-9-{[(2s)-1-hydroxy-3-(2-hydroxyphenyl)propan-2-yl]-c-hydroxycarbonimidoyl}non-8-enoic acid

C19H27NO5 (349.1889)


   

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

C20H31NO4 (349.2253)


   

5-hydroxy-4-(5-hydroxyhex-2-en-1-yl)-4-(2-methyl-6-oxooxan-4-yl)-2-(propan-2-ylidene)pyrrol-3-one

5-hydroxy-4-(5-hydroxyhex-2-en-1-yl)-4-(2-methyl-6-oxooxan-4-yl)-2-(propan-2-ylidene)pyrrol-3-one

C19H27NO5 (349.1889)


   

(1r,2r,10s,11s,12s,13r,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-12-yl acetate

(1r,2r,10s,11s,12s,13r,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-12-yl acetate

C20H31NO4 (349.2253)


   

(5S,6S,15R)-15-Methyllycopodane-5,6-diol 5,6-diacetate

NA

C20H31NO4 (349.2253)


{"Ingredient_id": "HBIN011943","Ingredient_name": "(5S,6S,15R)-15-Methyllycopodane-5,6-diol 5,6-diacetate","Alias": "NA","Ingredient_formula": "C20H31NO4","Ingredient_Smile": "CC1CC2C3CCCN4C3(C1)C(CCC4)C(C2OC(=O)C)OC(=O)C","Ingredient_weight": "349.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "459","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21576176","DrugBank_id": "NA"}

   

acetylfawcettiine

NA

C20H31NO4 (349.2253)


{"Ingredient_id": "HBIN014474","Ingredient_name": "acetylfawcettiine","Alias": "NA","Ingredient_formula": "C20H31NO4","Ingredient_Smile": "CC1CC23C4CCCN2CCCC3C(CC4C1OC(=O)C)OC(=O)C","Ingredient_weight": "349.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38577","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101500246","DrugBank_id": "NA"}

   

n-{5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl}dec-2-enimidic acid

n-{5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl}dec-2-enimidic acid

C19H27NO5 (349.1889)


   

(2s,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

(2s,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

C23H27NO2 (349.2042)


   

1-(3,7-dimethylocta-2,6-dien-1-yl)-3-methyl-9h-carbazole-2,7-diol

1-(3,7-dimethylocta-2,6-dien-1-yl)-3-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

n-{4-hydroxy-2-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

n-{4-hydroxy-2-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

C20H31NO4 (349.2253)


   

(1r,2r,10s,11r,13s,14r,15s)-14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

(1r,2r,10s,11r,13s,14r,15s)-14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C20H31NO4 (349.2253)


   

(1s,13s,15s,17r)-12,12,17-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s,17r)-12,12,17-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

n-{2-hydroxy-5-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

n-{2-hydroxy-5-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

C20H31NO4 (349.2253)


   

(2r,3s)-3-hydroxy-3-methyl-1-[(2r)-2-methylbutyl]-2-[(2e,4r)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

(2r,3s)-3-hydroxy-3-methyl-1-[(2r)-2-methylbutyl]-2-[(2e,4r)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

C21H35NO3 (349.2617)


   

(1s,2r,10r,11r,13r,14s,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-14-yl acetate

(1s,2r,10r,11r,13r,14s,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-14-yl acetate

C20H31NO4 (349.2253)


   

12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C21H23N3O2 (349.179)


   

3-hydroxy-3-methyl-1-(2-methylbutyl)-2-(4-methylhex-2-en-2-yl)-5-propanoyl-2h-pyridin-4-one

3-hydroxy-3-methyl-1-(2-methylbutyl)-2-(4-methylhex-2-en-2-yl)-5-propanoyl-2h-pyridin-4-one

C21H35NO3 (349.2617)


   

[(3r,5s,7ar,11ar)-5-hexyl-7-oxo-decahydropyrrolo[2,1-j]quinolin-3-yl]methyl acetate

[(3r,5s,7ar,11ar)-5-hexyl-7-oxo-decahydropyrrolo[2,1-j]quinolin-3-yl]methyl acetate

C21H35NO3 (349.2617)


   

2-methyl-5-(7-oxoocta-1,3-dien-1-yl)-decahydroquinolin-3-yl 2-hydroxyacetate

2-methyl-5-(7-oxoocta-1,3-dien-1-yl)-decahydroquinolin-3-yl 2-hydroxyacetate

C20H31NO4 (349.2253)


   

2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

C23H27NO2 (349.2042)


   

(1r,13r,15s,16s)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1r,13r,15s,16s)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

(4s,8z,11s,12e)-11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

(4s,8z,11s,12e)-11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C20H31NO2S (349.2075)


   

(4r)-5-hydroxy-4-[(2e)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4r)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

(4r)-5-hydroxy-4-[(2e)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4r)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

C19H27NO5 (349.1889)


   

(1s,13s,15r,16s)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15r,16s)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

(2s)-1-{[(3r,3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-9-methylidene-decahydronaphtho[1,2-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid

(2s)-1-{[(3r,3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-9-methylidene-decahydronaphtho[1,2-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid

C20H31NO4 (349.2253)


   

5,6-dihydroxy-7-isopropyl-5,6-dimethyl-4-methylidene-3-oxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-1(15)-en-8-one

5,6-dihydroxy-7-isopropyl-5,6-dimethyl-4-methylidene-3-oxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-1(15)-en-8-one

C20H31NO4 (349.2253)


   

1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3h,6h,7h-pyrrolo[1,2-a]pyrazin-4-one

1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3h,6h,7h-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O2 (349.179)


   

12-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

12-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C20H31NO4 (349.2253)


   

(4s)-5-hydroxy-4-[(2e)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4s)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

(4s)-5-hydroxy-4-[(2e)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4s)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

C19H27NO5 (349.1889)


   

{3-ethyl-8-hydroxy-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}acetic acid

{3-ethyl-8-hydroxy-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}acetic acid

C19H27NO5 (349.1889)


   

(4s)-5-hydroxy-4-[(2z)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4s)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

(4s)-5-hydroxy-4-[(2z)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4s)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

C19H27NO5 (349.1889)


   

(1s,4s,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

(1s,4s,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

C20H31NO4 (349.2253)


   

(2r,3s)-3-hydroxy-3-methyl-1-(3-methylbutyl)-2-[(2e,4s)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

(2r,3s)-3-hydroxy-3-methyl-1-(3-methylbutyl)-2-[(2e,4s)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

C21H35NO3 (349.2617)


   

{5-hexyl-7-oxo-decahydropyrrolo[2,1-j]quinolin-3-yl}methyl acetate

{5-hexyl-7-oxo-decahydropyrrolo[2,1-j]quinolin-3-yl}methyl acetate

C21H35NO3 (349.2617)


   

(2r,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

(2r,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

C23H27NO2 (349.2042)


   

(2r,3s)-3-hydroxy-3-methyl-1-[(2s)-2-methylbutyl]-2-[(2e,4r)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

(2r,3s)-3-hydroxy-3-methyl-1-[(2s)-2-methylbutyl]-2-[(2e,4r)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

C21H35NO3 (349.2617)


   

12,12,17-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

12,12,17-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8,18-pentaen-17-one

15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8,18-pentaen-17-one

C23H27NO2 (349.2042)


   

3-hydroxy-3-methyl-1-(2-methylbutyl)-2-[(2e)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

3-hydroxy-3-methyl-1-(2-methylbutyl)-2-[(2e)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

C21H35NO3 (349.2617)


   

3-hydroxy-3-methyl-1-(3-methylbutyl)-2-[(2e)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

3-hydroxy-3-methyl-1-(3-methylbutyl)-2-[(2e)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

C21H35NO3 (349.2617)


   

n-(4-hydroxy-2-{[(9-methyldecyl)oxy]carbonyl}phenyl)ethanimidic acid

n-(4-hydroxy-2-{[(9-methyldecyl)oxy]carbonyl}phenyl)ethanimidic acid

C20H31NO4 (349.2253)


   

14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C20H31NO4 (349.2253)


   

3-acetyl-1-(dec-2-enoyl)-4-hydroxy-5-(2-methylpropyl)-5h-pyrrol-2-one

3-acetyl-1-(dec-2-enoyl)-4-hydroxy-5-(2-methylpropyl)-5h-pyrrol-2-one

C20H31NO4 (349.2253)


   

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1e,3e)-7-oxoocta-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1e,3e)-7-oxoocta-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

C20H31NO4 (349.2253)


   

(13r,16s)-12,12,16-trimethyl-10,19,22-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-21-ol

(13r,16s)-12,12,16-trimethyl-10,19,22-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-21-ol

C22H27N3O (349.2154)


   

1-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-9h-carbazole-2,7-diol

1-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

3-hydroxy-3-methyl-1-(3-methylbutyl)-2-(4-methylhex-2-en-2-yl)-5-propanoyl-2h-pyridin-4-one

3-hydroxy-3-methyl-1-(3-methylbutyl)-2-(4-methylhex-2-en-2-yl)-5-propanoyl-2h-pyridin-4-one

C21H35NO3 (349.2617)


   

(2s)-2-(dimethylamino)-n-[2-(1h-indol-3-yl)-2-oxoethyl]-3-phenylpropanimidic acid

(2s)-2-(dimethylamino)-n-[2-(1h-indol-3-yl)-2-oxoethyl]-3-phenylpropanimidic acid

C21H23N3O2 (349.179)


   

(2e)-n-[(1s,2s,4's,5'r,6s)-5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl]dec-2-enimidic acid

(2e)-n-[(1s,2s,4's,5'r,6s)-5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl]dec-2-enimidic acid

C19H27NO5 (349.1889)


   

lecanindole a

lecanindole a

C23H27NO2 (349.2042)


   

[(2r,3r,11bs)-3-ethyl-8-hydroxy-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]acetic acid

[(2r,3r,11bs)-3-ethyl-8-hydroxy-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]acetic acid

C19H27NO5 (349.1889)


   

(1s,4r,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

(1s,4r,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

C20H31NO4 (349.2253)


   

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9h-carbazole-2,7-diol

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

(2s,3r)-3-hydroxy-3-methyl-1-(3-methylbutyl)-2-[(2e,4r)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

(2s,3r)-3-hydroxy-3-methyl-1-(3-methylbutyl)-2-[(2e,4r)-4-methylhex-2-en-2-yl]-5-propanoyl-2h-pyridin-4-one

C21H35NO3 (349.2617)